| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |